These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 8726592

  • 1. Metformin in noninsulin-dependent diabetes mellitus.
    Lee AJ.
    Pharmacotherapy; 1996; 16(3):327-51. PubMed ID: 8726592
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus.
    Wildasin EM, Skaar DJ, Kirchain WR, Hulse M.
    Pharmacotherapy; 1997; 17(1):62-73. PubMed ID: 9017766
    [Abstract] [Full Text] [Related]

  • 4. Metformin: a safe and effective treatment in the management of NIDDM.
    Kilo C.
    Mo Med; 1997 Mar; 94(3):114-23. PubMed ID: 9071866
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH, Elte JW, Lehert P, Schouten JP, Bets D.
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [Abstract] [Full Text] [Related]

  • 7. [Therapeutic utility of biguanides in the treatment of NIDDM].
    Fujimoto S.
    Nihon Rinsho; 1999 Mar; 57(3):657-62. PubMed ID: 10199150
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
    Bosi E.
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
    [Abstract] [Full Text] [Related]

  • 10. New oral therapies for type 2 diabetes.
    Purnell JQ, Hirsch IB.
    Am Fam Physician; 1997 Nov 01; 56(7):1835-42. PubMed ID: 9371013
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Metformin: diamonds are forever.
    Papanas N, Maltezos E, Mikhailidis DP.
    Expert Opin Pharmacother; 2009 Oct 01; 10(15):2395-7. PubMed ID: 19678795
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Balancing risk and benefit with oral hypoglycemic drugs.
    Hamnvik OP, McMahon GT.
    Mt Sinai J Med; 2009 Jun 01; 76(3):234-43. PubMed ID: 19421967
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P, Sitagliptin Study 035 Group.
    Diabetes Obes Metab; 2007 Sep 01; 9(5):733-45. PubMed ID: 17593236
    [Abstract] [Full Text] [Related]

  • 16. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug 01; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

  • 17. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents.
    Goodarzi MO, Bryer-Ash M.
    Diabetes Obes Metab; 2005 Nov 01; 7(6):654-65. PubMed ID: 16219009
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.